Home

David D O'Toole

CIK 1491140 · CFO · last filed 2026-08-24

David D O'Toole is a CFO who has filed 76 SEC Form 4 insider transactions across 7 companies since 2010. The most recent filing shows the insider bought $7.9K of RCEL on Aug 24, 2026. Across all open-market trades the lifetime net is +$619.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.68M

Companies

7

Total Filings

76

Lifetime Open-Market Net

$619.6K

Filer Profile

Reported Address
28159 AVENUE STANFORD, SUITE 220
VALENCIA, CA 91355
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RCEL CFO 152,927 $9.88 $1.51M $356.0K 27 2026-08-24
OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted Chief Financial Officer 0 $20.65 $0 $113.7K 24 2023-03-03
SOLENO THERAPEUTICS INC (CAPNW) Delisted Director — — — $0 1 2017-04-24
SOLENO THERAPEUTICS INC (CAPN.W) Delisted See Remarks 44,750 — — $94.4K 12 2016-08-19
CDXS SVP & Chief Financial Officer 110,687 $1.47 $162.2K $45.1K 6 2013-09-06
MNOV Director 5,000 $1.81 $9.1K $8.9K 2 2012-05-30
RESPONSE GENETICS INC (RGDX) Delisted VP and Chief Financial Officer 1,000 — — $1.5K 4 2012-02-06

Recent Filings

76 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-24 RCEL Buy (P) +2,000 $7.9K EDGAR
2026-06-12 RCEL Grant (A) +2,000 $7.9K EDGAR
2026-06-01 RCEL Grant (A) +5,000 $15.3K EDGAR
2026-05-20 RCEL Buy (P) +2,000 $8.5K EDGAR
2026-05-19 RCEL Buy (P) +2,000 $8.5K EDGAR
2026-03-11 RCEL Buy (P) +1,800 $8.6K EDGAR
2026-02-23 RCEL Buy (P) +3,000 $12.5K EDGAR
2026-02-19 RCEL Grant (A) +105,470 $0 EDGAR
2025-08-26 RCEL Buy (P) +2,000 $9.0K EDGAR
2025-08-12 RCEL Buy (P) +2,000 $9.6K EDGAR
Showing 1–10 of 76
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.